Schneider, F.; Clère-Jehl, R.; Scavello, F.; Lavigne, T.; Corti, A.; Angelone, T.; Haïkel, Y.; Lavalle, P.
Chromogranin A and Its Fragments in the Critically Ill: An Expanding Domain of Interest for Better Care. Pharmaceutics 2022, 14, 2178.
https://doi.org/10.3390/pharmaceutics14102178
AMA Style
Schneider F, Clère-Jehl R, Scavello F, Lavigne T, Corti A, Angelone T, Haïkel Y, Lavalle P.
Chromogranin A and Its Fragments in the Critically Ill: An Expanding Domain of Interest for Better Care. Pharmaceutics. 2022; 14(10):2178.
https://doi.org/10.3390/pharmaceutics14102178
Chicago/Turabian Style
Schneider, Francis, Raphaël Clère-Jehl, Francesco Scavello, Thierry Lavigne, Angelo Corti, Tommaso Angelone, Youssef Haïkel, and Philippe Lavalle.
2022. "Chromogranin A and Its Fragments in the Critically Ill: An Expanding Domain of Interest for Better Care" Pharmaceutics 14, no. 10: 2178.
https://doi.org/10.3390/pharmaceutics14102178
APA Style
Schneider, F., Clère-Jehl, R., Scavello, F., Lavigne, T., Corti, A., Angelone, T., Haïkel, Y., & Lavalle, P.
(2022). Chromogranin A and Its Fragments in the Critically Ill: An Expanding Domain of Interest for Better Care. Pharmaceutics, 14(10), 2178.
https://doi.org/10.3390/pharmaceutics14102178